Drug General Information
Drug ID	D0R5UZ
Former ID	DIB002701
Drug Name	Caracemide
Synonyms	NSC-253272
Drug Type	Small molecular drug
Indication	Cancer [ICD9: 140-229; ICD10:C00-C96]		Discontinued in Phase 2	[544726]
Company	Hoechst Marion Roussel Inc
Structure		Download 2D MOL 3D MOL
Formula	C6H11N3O4
Canonical SMILES	N(C(=O)NC)(C(=O)C)OC(=O)NC
CAS Number	CAS 81424-67-1
PubChem Compound ID	54747
Target and Pathway
Target(s)	Acetylcholinesterase	Target Info	Inhibitor	[533460]
KEGG Pathway	Glycerophospholipid metabolism
	Cholinergic synapse
PANTHER Pathway	Muscarinic acetylcholine receptor 1 and 3 signaling pathway
	Muscarinic acetylcholine receptor 2 and 4 signaling pathway
	Nicotinic acetylcholine receptor signaling pathway
Pathway Interaction Database	ATF-2 transcription factor network
PathWhiz Pathway	Phospholipid Biosynthesis
WikiPathways	Monoamine Transport
	Biogenic Amine Synthesis
	Acetylcholine Synthesis
	Integrated Pancreatic Cancer Pathway
References
Ref 544726	Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800000740)
Ref 533460	Biochemical pharmacology of N-acetyl-N-(methylcarbamoyloxy)-N'-methylurea (caracemide; NSC-253272). Biochem Pharmacol. 1986 Aug 15;35(16):2781-7.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.